Toews Corporation’s Merck MRK Stock Holding History

Toews Corporation’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-7,500	Closed	-$772K	–	81
2023 Q3	$772K	Buy	+7,500	New	+$808K	0.47%	56
2023 Q1	–	Sell	-7,000	Closed	-$777K	–	92
2022 Q4	$777K	Sell	7,000 -6,700	-49%	-$685K	0.38%	59
2022 Q3	$1.18M	Buy	+13,700	New	+$1.22M	0.87%	6
2021 Q4	–	Sell	-5,600	Closed	-$421K	–	88
2021 Q3	$421K	Buy	+5,600	New	+$426K	0.05%	23
2021 Q2	–	Sell	-12,786	Closed	-$940K	–	85
2021 Q1	$940K	Buy	+12,786	New	+$943K	0.08%	71
2020 Q4	–	Sell	-12,262	Closed	-$971K	–	88
2020 Q3	$971K	Buy	+12,262	New	+$960K	0.29%	97
2020 Q2	–	Sell	-11,528	Closed	-$846K	–	76
2020 Q1	$846K	Buy	+11,528	New	+$906K	0.77%	47
2019 Q1	–	Sell	-14,148	Closed	-$1.03M	–	74
2018 Q4	$1.03M	Buy	+14,148	New	+$999K	0.45%	43

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Toews Corporation's MRK Position: Q4 2023 in Review

Toews Corporation sold out of Merck (MRK) in Q4 2023, closing a stake of 7,500 shares — an estimated $772K sold.

Toews Corporation first reported a position in MRK in Q4 2018 and held it in 8 quarters. The position peaked at $1.18M in Q3 2022. 3,434 funds tracked by Wall St. Rank hold MRK as of Q4 2023.

Toews Corporation reported no remaining Merck position as of Q4 2023 after selling out during the quarter.
Toews Corporation sold 7,500 Merck shares in Q4 2023, an estimated $772K.
Toews Corporation first reported a position in Merck in Q4 2018 and held it in 8 quarters.
Toews Corporation's Merck position peaked at $1.18M in Q3 2022.
3,434 funds tracked by Wall St. Rank held Merck as of Q4 2023.

Based on Toews Corporation's 13F filing for Q4 2023, filed 17 Jan 2024.